← Eichor
Study identifier: NCT06520020 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluating Safety and Feasibility of Transcutaneous Spinal Cord Stimulation Following Traumatic and Non-Traumatic Spinal Cord Injury: A Pilot Study

Condition: Spinal Cord Stimulation · Electric Stimulation Therapy · Traumatic Spinal Cord Injury  ·  Sponsor: Francis Farhadi

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The study will be a non-randomized, non-blinded pilot study to analyze the safety and feasibility of a non-significant risk device, transcutaneous spinal cord stimulation. The aim is to include 30 total patients, 10 patients in each of 3 groups: 1. Non-traumatic spinal cord injury (ntSCI) with diagnosis of degenerative cervical myelopathy and offered surgical intervention. 2. Early tSCI screened during the hospital admission when cervical/thoracic spinal injury was diagnosed. 3. Delayed tSCI (control) screened 6-24 months after acute cervical/thoracic spinal injury.

This description comes directly from the study's public registry record.

Talk to the study team

H. Francis Farhadi, MD, PhD  ·  859-323-5661  ·  francis.farhadi@uky.edu

Kris P Dyer, MPH, BS  ·  859-323-4533  ·  kris.dyer@uky.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Kentucky - Chandler Medical CenterLexington, Kentucky, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06520020